NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI

NCT05638867 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

3944

Enrollment

OTHER_GOV

Sponsor class

Conditions

Coronary Artery Disease
Percutaneous Coronary Intervention
Acute Coronary Syndrome

Interventions

DRUG: Aspirin + Clopidogrel + Rivaroxaban
DRUG: Aspirin + Clopidogrel

Sponsor

China National Center for Cardiovascular Diseases